Skip to main content
Top
SPONSORED

Podcast synopsis of updates to the European Renal Best Practice and UK Kidney Association guidelines for treatment of anemia in chronic kidney disease

Hosts:
Prof. Mario Cozzolino

University of Milan and ASST Santi Paolo and Carlo Hospitals, Milan, Italy

Dr. Sokratis Stoumpos

Queen Elizabeth University Hospital, Glasgow, UK

Prof. Sunil Bhandari

Hull York Medical School, York, UK, and Hull University Teaching Hospitals NHS Trust, Hull, UK

This podcast offers a clinical overview of recent updates to the European Renal Best Practice (ERBP) and UK Kidney Association (UKKA) guidelines for the treatment of anemia associated with chronic kidney disease (CKD). It focuses on the role of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) as an alternative to erythropoiesis-stimulating agents (ESAs) for the treatment of anemia of CKD. The discussion encompasses efficacy, safety, and prescribing considerations for specific patient groups, including those with inflammation, a cardiovascular history, or a history of kidney transplants. The podcast aims to support clinicians in making informed, individualized treatment decisions based on the latest evidence and guideline recommendations.

Image Credits
Adis Journal Podcast/© Adis